323 related articles for article (PubMed ID: 12384496)
1. Initial characterization of the glutamate-cysteine ligase modifier subunit Gclm(-/-) knockout mouse. Novel model system for a severely compromised oxidative stress response.
Yang Y; Dieter MZ; Chen Y; Shertzer HG; Nebert DW; Dalton TP
J Biol Chem; 2002 Dec; 277(51):49446-52. PubMed ID: 12384496
[TBL] [Abstract][Full Text] [Related]
2. Knockout of the mouse glutamate cysteine ligase catalytic subunit (Gclc) gene: embryonic lethal when homozygous, and proposed model for moderate glutathione deficiency when heterozygous.
Dalton TP; Dieter MZ; Yang Y; Shertzer HG; Nebert DW
Biochem Biophys Res Commun; 2000 Dec; 279(2):324-9. PubMed ID: 11118286
[TBL] [Abstract][Full Text] [Related]
3. Glutamate cysteine ligase catalysis: dependence on ATP and modifier subunit for regulation of tissue glutathione levels.
Chen Y; Shertzer HG; Schneider SN; Nebert DW; Dalton TP
J Biol Chem; 2005 Oct; 280(40):33766-74. PubMed ID: 16081425
[TBL] [Abstract][Full Text] [Related]
4. Differential regulation of glutamate-cysteine ligase subunit expression and increased holoenzyme formation in response to cysteine deprivation.
Lee JI; Kang J; Stipanuk MH
Biochem J; 2006 Jan; 393(Pt 1):181-90. PubMed ID: 16137247
[TBL] [Abstract][Full Text] [Related]
5. Modulating GSH synthesis using glutamate cysteine ligase transgenic and gene-targeted mice.
Botta D; White CC; Vliet-Gregg P; Mohar I; Shi S; McGrath MB; McConnachie LA; Kavanagh TJ
Drug Metab Rev; 2008; 40(3):465-77. PubMed ID: 18642143
[TBL] [Abstract][Full Text] [Related]
6. Glutamate cysteine ligase (GCL) transgenic and gene-targeted mice for controlling glutathione synthesis.
Mohar I; Botta D; White CC; McConnachie LA; Kavanagh TJ
Curr Protoc Toxicol; 2009 Feb; Chapter 6():Unit6.16. PubMed ID: 23045016
[TBL] [Abstract][Full Text] [Related]
7. Increased sensitivity to testicular toxicity of transplacental benzo[a]pyrene exposure in male glutamate cysteine ligase modifier subunit knockout (Gclm-/-) mice.
Nakamura BN; Mohar I; Lawson GW; Cortés MM; Hoang YD; Ortiz L; Patel R; Rau BA; McConnachie LA; Kavanagh TJ; Luderer U
Toxicol Sci; 2012 Mar; 126(1):227-41. PubMed ID: 22253057
[TBL] [Abstract][Full Text] [Related]
8. Interaction between the catalytic and modifier subunits of glutamate-cysteine ligase.
Yang Y; Chen Y; Johansson E; Schneider SN; Shertzer HG; Nebert DW; Dalton TP
Biochem Pharmacol; 2007 Jul; 74(2):372-81. PubMed ID: 17517378
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of glutamate-cysteine ligase protects human COV434 granulosa tumour cells against oxidative and gamma-radiation-induced cell death.
Cortes-Wanstreet MM; Giedzinski E; Limoli CL; Luderer U
Mutagenesis; 2009 May; 24(3):211-24. PubMed ID: 19153097
[TBL] [Abstract][Full Text] [Related]
10. Glutathione-deficient mice are susceptible to TCDD-Induced hepatocellular toxicity but resistant to steatosis.
Chen Y; Krishan M; Nebert DW; Shertzer HG
Chem Res Toxicol; 2012 Jan; 25(1):94-100. PubMed ID: 22082335
[TBL] [Abstract][Full Text] [Related]
11. Glutamate-cysteine ligase modifier subunit: mouse Gclm gene structure and regulation by agents that cause oxidative stress.
Solis WA; Dalton TP; Dieter MZ; Freshwater S; Harrer JM; He L; Shertzer HG; Nebert DW
Biochem Pharmacol; 2002 May; 63(9):1739-54. PubMed ID: 12007577
[TBL] [Abstract][Full Text] [Related]
12. Structure, function, and post-translational regulation of the catalytic and modifier subunits of glutamate cysteine ligase.
Franklin CC; Backos DS; Mohar I; White CC; Forman HJ; Kavanagh TJ
Mol Aspects Med; 2009; 30(1-2):86-98. PubMed ID: 18812186
[TBL] [Abstract][Full Text] [Related]
13. Minimal ovarian upregulation of glutamate cysteine ligase expression in response to suppression of glutathione by buthionine sulfoximine.
Hoang YD; Avakian AP; Luderer U
Reprod Toxicol; 2006 Feb; 21(2):186-96. PubMed ID: 16183247
[TBL] [Abstract][Full Text] [Related]
14. Rapid activation of glutamate cysteine ligase following oxidative stress.
Krejsa CM; Franklin CC; White CC; Ledbetter JA; Schieven GL; Kavanagh TJ
J Biol Chem; 2010 May; 285(21):16116-24. PubMed ID: 20332089
[TBL] [Abstract][Full Text] [Related]
15. Distinct Nrf1/2-independent mechanisms mediate As 3+-induced glutamate-cysteine ligase subunit gene expression in murine hepatocytes.
Thompson JA; White CC; Cox DP; Chan JY; Kavanagh TJ; Fausto N; Franklin CC
Free Radic Biol Med; 2009 Jun; 46(12):1614-25. PubMed ID: 19328227
[TBL] [Abstract][Full Text] [Related]
16. Molecular cloning and analysis of Ancylostoma ceylanicum glutamate-cysteine ligase.
Wiśniewski M; Lapiński M; Zdziarska A; Długosz E; Bąska P
Mol Biochem Parasitol; 2014 Aug; 196(1):12-20. PubMed ID: 25092620
[TBL] [Abstract][Full Text] [Related]
17. Manipulation of cellular GSH biosynthetic capacity via TAT-mediated protein transduction of wild-type or a dominant-negative mutant of glutamate cysteine ligase alters cell sensitivity to oxidant-induced cytotoxicity.
Backos DS; Brocker CN; Franklin CC
Toxicol Appl Pharmacol; 2010 Feb; 243(1):35-45. PubMed ID: 19914271
[TBL] [Abstract][Full Text] [Related]
18. Curcumin, quercetin, and tBHQ modulate glutathione levels in astrocytes and neurons: importance of the glutamate cysteine ligase modifier subunit.
Lavoie S; Chen Y; Dalton TP; Gysin R; Cuénod M; Steullet P; Do KQ
J Neurochem; 2009 Mar; 108(6):1410-22. PubMed ID: 19183254
[TBL] [Abstract][Full Text] [Related]
19. Mice lacking the glutamate-cysteine ligase modifier subunit are susceptible to myocardial ischaemia-reperfusion injury.
Kobayashi T; Watanabe Y; Saito Y; Fujioka D; Nakamura T; Obata JE; Kitta Y; Yano T; Kawabata K; Watanabe K; Mishina H; Ito S; Kugiyama K
Cardiovasc Res; 2010 Mar; 85(4):785-95. PubMed ID: 19837697
[TBL] [Abstract][Full Text] [Related]
20. Posttranslational modification and regulation of glutamate-cysteine ligase by the α,β-unsaturated aldehyde 4-hydroxy-2-nonenal.
Backos DS; Fritz KS; Roede JR; Petersen DR; Franklin CC
Free Radic Biol Med; 2011 Jan; 50(1):14-26. PubMed ID: 20970495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
